Search research articles
Contact Us
Filters
Showing results (281-290 of 343) with videos related to
Page
of 35
Sort By:
Investigational New Drugs
|
September 10, 2020
Immunologic and tumor responses of pegilodecakin with 5-FU/LV and oxaliplatin (FOLFOX) in pancreatic ductal adenocarcinoma (PDAC)
J Randolph Hecht, Kyriakos P Papadopoulos, Gerald S Falchook, et al.
JCO Precision Oncology
|
March 2, 2026
Molecular Profiling of Cholangiocarcinoma Predicts Outcomes Post-Liver Transplantation
Ashton A Connor, Mahinur Mattohti, Sudha Kodali, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 13, 2026
A Phase 2 Trial of an Extended-release siRNA Implant Targeting KRAS G12D/V in Locally Advanced Pancreatic Cancer
Brinda Alagesan, Anna M Varghese, Celina Ang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 8, 2024
Utilizing Patient-Derived Xenografts to Model Precision Oncology for Biliary Tract Cancer
Timothy P DiPeri, Kurt W Evans, Stephen Scott, et al.
British Journal of Cancer
|
February 3, 2017
A phase 1 dose-escalation and expansion study of binimetinib (MEK162), a potent and selective oral MEK1/2 inhibitor
Johanna C Bendell, Milind Javle, Tanios S Bekaii-Saab, et al.
The Oncologist
|
January 10, 2026
Actionable Genomic Landscape of Biliary Tract Cancer in the Indian Population
Sewanti Limaye, Aditya Shreenivas, Darshana Patil, et al.
Journal for Immunotherapy of Cancer
|
February 3, 2024
Efficacy and safety of autologous tumor-infiltrating lymphocytes in recurrent or refractory ovarian cancer, colorectal cancer, and pancreatic ductal adenocarcinoma
Rodabe Amaria, Anne Knisely, David Vining, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
June 20, 2025
Population-Specific Immunogenomic Alterations in Gallbladder Cancer and Prognostic Significance
Yan Zhu, Luisa Maren Solis Soto, Shubham Pant, et al.
Cancer Discovery
|
July 18, 2022
Single-Cell Sequencing Reveals Trajectory of Tumor-Infiltrating Lymphocyte States in Pancreatic Cancer
Aislyn Schalck, Donastas Sakellariou-Thompson, Marie-Andrée Forget, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
October 13, 2016
Preoperative Chemoradiation for Pancreatic Adenocarcinoma Does Not Increase 90-Day Postoperative Morbidity or Mortality
Jason W Denbo, Morgan L Bruno, Jordan M Cloyd, et al.
Page
of 35
Search research articles
Search
Showing results (281-290 of 343) with videos related to
Sort By:
Page
of 35
Investigational New Drugs
|
September 10, 2020
Immunologic and tumor responses of pegilodecakin with 5-FU/LV and oxaliplatin (FOLFOX) in pancreatic ductal adenocarcinoma (PDAC)
J Randolph Hecht, Kyriakos P Papadopoulos, Gerald S Falchook, et al.
JCO Precision Oncology
|
March 2, 2026
Molecular Profiling of Cholangiocarcinoma Predicts Outcomes Post-Liver Transplantation
Ashton A Connor, Mahinur Mattohti, Sudha Kodali, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 13, 2026
A Phase 2 Trial of an Extended-release siRNA Implant Targeting KRAS G12D/V in Locally Advanced Pancreatic Cancer
Brinda Alagesan, Anna M Varghese, Celina Ang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 8, 2024
Utilizing Patient-Derived Xenografts to Model Precision Oncology for Biliary Tract Cancer
Timothy P DiPeri, Kurt W Evans, Stephen Scott, et al.
British Journal of Cancer
|
February 3, 2017
A phase 1 dose-escalation and expansion study of binimetinib (MEK162), a potent and selective oral MEK1/2 inhibitor
Johanna C Bendell, Milind Javle, Tanios S Bekaii-Saab, et al.
The Oncologist
|
January 10, 2026
Actionable Genomic Landscape of Biliary Tract Cancer in the Indian Population
Sewanti Limaye, Aditya Shreenivas, Darshana Patil, et al.
Journal for Immunotherapy of Cancer
|
February 3, 2024
Efficacy and safety of autologous tumor-infiltrating lymphocytes in recurrent or refractory ovarian cancer, colorectal cancer, and pancreatic ductal adenocarcinoma
Rodabe Amaria, Anne Knisely, David Vining, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
June 20, 2025
Population-Specific Immunogenomic Alterations in Gallbladder Cancer and Prognostic Significance
Yan Zhu, Luisa Maren Solis Soto, Shubham Pant, et al.
Cancer Discovery
|
July 18, 2022
Single-Cell Sequencing Reveals Trajectory of Tumor-Infiltrating Lymphocyte States in Pancreatic Cancer
Aislyn Schalck, Donastas Sakellariou-Thompson, Marie-Andrée Forget, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
October 13, 2016
Preoperative Chemoradiation for Pancreatic Adenocarcinoma Does Not Increase 90-Day Postoperative Morbidity or Mortality
Jason W Denbo, Morgan L Bruno, Jordan M Cloyd, et al.
Page
of 35